n-formylmethionine leucyl-phenylalanine has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bast, RC; Knapp, RC; Leavitt, T; Obrist, R; Reilly, R | 1 |
| Banks, SM; Buescher, ES; Kavanagh, JJ; Kudelka, AP; McIlheran, SM; Vadhan-Raj, S | 1 |
| Cianciolo, GJ; Mantovani, A; Snyderman, R; Wang, JM | 1 |
1 trial(s) available for n-formylmethionine leucyl-phenylalanine and Cancer of Ovary
| Article | Year |
|---|---|
The effects of interleukin-1 therapy on peripheral blood granulocyte function in humans.
Topics: Analysis of Variance; Cell Movement; Chemotaxis, Leukocyte; Dose-Response Relationship, Immunologic; Female; Granulocytes; Humans; Hydrogen Peroxide; Infusions, Intravenous; Interleukin-1; Male; N-Formylmethionine Leucyl-Phenylalanine; Ovarian Neoplasms; Recombinant Proteins; Respiratory Burst; Tetradecanoylphorbol Acetate | 1993 |
2 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Cancer of Ovary
| Article | Year |
|---|---|
Monocyte chemotaxis mediated by formyl-methionyl-leucyl-phenylalanine conjugated with monoclonal antibodies against human ovarian carcinoma.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Carcinoma; Cells, Cultured; Chemotaxis, Leukocyte; Female; Humans; Macrophages; N-Formylmethionine Leucyl-Phenylalanine; Ovarian Neoplasms | 1983 |
Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants.
Topics: Antigen-Antibody Complex; Cell Line; Chemotactic Factors; Chemotaxis, Leukocyte; Culture Media; Female; Humans; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Ovarian Neoplasms; Retroviridae; Sarcoma | 1986 |